Number VII Behçet's disease (Adamantiades syndrome)

Oral Diseases

Volumn 12, Issue 2, 2006, Pages 78-84

  Escudier, M ^a   Bagan, J ^b   Scully, C ^c,d  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF VALENCIA   (Spain)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

^d UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Aphthae; Autoimmune; Beh et syndrome; Immunosuppressants; Oral

Indexed keywords

ALPHA2A INTERFERON; AZATHIOPRINE; CHLORAMBUCIL; COLCHICINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN; DAPSONE; HEAT SHOCK PROTEIN; HLA ANTIGEN; HLA B5 ANTIGEN; HLA B51 ANTIGEN; IMMUNOSUPPRESSIVE AGENT; INFLIXIMAB; LEVAMISOLE; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PENTOXIFYLLINE; THALIDOMIDE; TSUKUBAENOLIDE; TUMOR NECROSIS FACTOR ALPHA ANTIBODY; UNCLASSIFIED DRUG;

ANTIGEN ANTIBODY COMPLEX; APHTHOUS STOMATITIS; ARTHRALGIA; ARTICLE; AUTOIMMUNE DISEASE; BEHCET DISEASE; CENTRAL NERVOUS SYSTEM DISEASE; CLINICAL FEATURE; CLINICAL TRIAL; DIAGNOSTIC PROCEDURE; DIFFERENTIAL DIAGNOSIS; DISEASE EXACERBATION; EYE DISEASE; GENITAL ULCER; HUMAN; IMMUNOMODULATION; INFLAMMATORY DISEASE; IRIDOCYCLITIS; LEUKOCYTOSIS; MOUTH LESION; MUCOSAL DISEASE; PRIORITY JOURNAL; REMISSION; SKIN DEFECT; SYSTEMIC VASCULITIS; VASCULITIS;

AUTOIMMUNE DISEASES; BEHCET SYNDROME; EYE DISEASES; FEMALE UROGENITAL DISEASES; HEAT-SHOCK PROTEINS; HUMANS; IMMUNE COMPLEX DISEASES; MALE UROGENITAL DISEASES; SKIN ULCER; STOMATITIS, APHTHOUS; VASCULITIS;

EID: 33645115274     PISSN: 1354523X     EISSN: 16010825     Source Type: Journal    
DOI: 10.1111/j.1601-0825.2005.01144.x     Document Type: Article

References (28)

1. Alpsoy E Durusoy C Yilmaz E et al 2002 Interferon alfa-2a in the treatment of Behcet disease: a randomized placebo-controlled and double-blind study Arch Dermatol 138 467 471
2. Bastuji-Garin S Ochonisky S Bouche P et al 2002 Incidence and risk factors for thalidomide neuropathy: a prospective study of 135 dermatologic patients J Invest Dermatol 119 1020 1026
3. Cantini F Emmi L Niccoli L Padula A Salvarani C Olivieri I 1997 Lack of association between chronic hepatitis C virus infection and Behcet's disease Clin Exp Rheumatol 15 338 339
4. Dilsen N 2000 Risk factors in Behcets disease In: Bang E Lee L Lee S eds. Behcet's disease Design Mecca Publishing Seoul pp 511 514
5. Direskeneli H Eksioglu-Demiralp E Yavuz S et al 2000 T cell responses to 60/65 kDa heat shock protein derived peptides in Turkish patients with Behcet's disease J Rheumatol 27 708 713
6. Freysdottir J Lau S Fortune F 1999 Gammadelta T cells in Behcet's disease (BD) and recurrent aphthous stomatitis (RAS) Clin Exp Immunol 118 451 457
7. Gul A Hajeer AH Worthington J Ollier WE Silman AJ 2001 Linkage mapping of a novel susceptibility locus for Behcet's disease to chromosome 6p22-23 Arthritis Rheum 44 2693 2696
8. Hamuryudan V Mat C Saip S et al 1998 Thalidomide in the treatment of the mucocutaneous lesions of the Behcet syndrome. A randomized, double-blind, placebo-controlled trial Ann Intern Med 128 443 450
9. Hamuryudan V Ozyazgan Y Hizli N et al 1997 Azathioprine in Behcet's syndrome: effects on long-term prognosis Arthritis Rheum 40 769 774
10. Hasan A Fortune F Wilson A et al 1996 Role of gamma delta T cells in pathogenesis and diagnosis of Behcet's disease Lancet 347 789 794
11. Ilter N Senol E Gurer MA Oztas MO 2000 Behcet's disease and HCV infection Int J Dermatol 39 396 397
12. Lehner T 1997 The role of heat shock protein, microbial and autoimmune agents in the aetiology of Behcet's disease Int Rev Immunol 14 21 32
13. Matsuo T Itami M Nakagawa H Nagayama M 2002 The incidence and pathology of conjunctival ulceration in Behcet's syndrome Br J Ophthalmol 86 140 143
14. Mizuki N Inoko H Ohno S 1997 Molecular genetics (HLA) of Behcet's disease Yonsei Med J 38 333 349
15. Mizuki N Ota M Katsuyama Y et al 2001 HLA class I genotyping including HLA-B*51 allele typing in the Iranian patients with Behcet's disease Tissue Antigens 57 457 462
16. Pervin K Childerstone A Shinnick T et al 1993 T cell epitope expression of mycobacterial and homologous human 65-kilodalton heat shock protein peptides in short term cell lines from patients with Behcet's disease J Immunol 151 2273 2282
17. Siva A 2001 Vasculitis of the nervous system J Neurol 248 451 468
18. Sloper CM Powell RJ Dua HS 1999 Tacrolimus (FK506) in the treatment of posterior uveitis refractory to cyclosporine Ophthalmology 106 723 728
19. Stokes DG Kremer JM 2003 Potential of tumour necrosis factor neutralization strategies in rheumatologic disorders other than rheumatoid arthritis Semin Arthritis Rheum 33 1 18
20. Verity DH Marr JE Ohno S Wallace GR Stanford MR 1999a Behcet's disease, the Silk Road and HLA-B51: historical and geographical perspectives Tissue Antigens 54 213 220
21. Verity DH Wallace GR Vaughan RW et al 1999b HLA and tumour necrosis factor (TNF) polymorphisms in ocular Behcet's disease Tissue Antigens 54 264 272
22. Verity DH Wallace GR Vaughan RW Stanford MR 2003a Behcet's disease: from Hippocrates to the third millennium Br J Ophthalmol 87 1175 1183
23. Verity DH Wallace GR Vaughan RW Stanford MR 2003b Behcet's disease: from Hippocrates to the third millennium Br J Ophthalmol 87 1175 1183
24. Verity DH Wallace GR Vaughan RW Stanford MR 2003c Behcet's disease: from Hippocrates to the third millennium Br J Ophthalmol 87 1175 1183
25. Wallace GR Verity DH Delamaine LJ et al 1999 MIC-A allele profiles and HLA class I associations in Behcet's disease Immunogenetics 49 613 617
26. Yazici H Pazarli H Barnes CG et al 1990 A controlled trial of azathioprine in Behcet's syndrome N Engl J Med 322 281 285
27. Yurdakul S Mat C Tuzun Y et al 2001 A double-blind trial of colchicine in Behcet's syndrome Arthritis Rheum 44 2686 2692
28. Zouboulis CC Turnbull JR Muhlradt PF 2003 Association of Mycoplasma fermentans with Adamantiades-Behcet's disease Adv Exp Med Biol 528 191 194